Stock Market News

FDA reviews GSK’s depemokimab for asthma, CRSwNP; decision due Dec. 16

Mar 3, 2025 - 09:14
 0
FDA reviews GSK’s depemokimab for asthma, CRSwNP; decision due Dec. 16
Read More

Tags:

Previous Article

Greenhaven Road Capital Main Fund Q4 2024 Investor Letter

Next Article

European stocks rise ahead of key inflation data; ECB meeting looms

Related Posts

Colombia stocks lower at close of trade; COLCAP down 0.33%

Colombia stocks lower at close of trade; COLCAP down 0.33%

Feb 12, 2025  0

Compass stock surges on robust Q4 revenue growth

Compass stock surges on robust Q4 revenue growth

Feb 19, 2025  0

Kingspan stock jumps 13% after beating estimates

Kingspan stock jumps 13% after beating estimates

Feb 21, 2025  0